EGFR and glioblastoma: Conversely, IDH wild-type tumors that do not fulfill morphological WHO grade 4 criteria are still diagnosed as glioblastoma if they exhibit at least one of the following alterations: EGFR amplification, a + 7/−10 genotype or TERT promoter mutation11.